Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
Clinical trial NCT04936971 · WITHDRAWN
Trial details
- NCT number
- NCT04936971
- Sponsor
- Edoardo Melilli
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2021-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.